Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rifaximin and FMT in IBS-D
NCT02651740Phase 3Unknown
- Sponsor
- Zhongshan Hospital, Fudan University
- Start
- Apr 2016
- Primary completion
- Jul 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of rifaximin in Irritable bowel syndrome with diarrhea (IBS-D), sponsored by Zhongshan Hospital, Fudan University. Status: unknown.
02
Drugs
rifaximin
03
Conditions
Irritable bowel syndrome with diarrhea (IBS-D)
Beyond the preview
Go deeper on NCT02651740.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02651740.